This study evaluated clinical outcome and safety of radiosurgery using the Cyberknife for treatment of benign spinal tumors. The authors treated 30 benign spinal tumors in 20 patients with the Cyberknife (Accuray, Inc., Sunnyvale, CA, USA) from 2002 to 2008. Among these there were 20 neurogenic tumors, eight hemangioblastomas, and two meningiomas. Four patients with neurofibromatosis (NF) type 2 and four patients with Von Hippel Lindau disease were also included. Radiosurgery was done as primary treatment for 22 lesions, for postoperative residual tumor control for four lesions, and for the remaining four lesions with image-based progression after initial subtotal resection. The distribution of lesions was cervical (18 tumors), thoracic (six), and cauda equina level (six). Follow-up data included imaging studies, clinical findings, and radiotherapy data. Tumor volume ranged from 0.04 to 33.65 cm3 (mean, 4.52 cm3). A 14–33 Gy marginal dose was delivered in 1–5 fractions. The mean follow-up period was 35.6 months (range, 12–84 months). On follow-up, most lesions decreased in size (57%) or remained unchanged (33%). Two lesions initially decreased, then increased later. One lesion increased without response. With regard to clinical aspects, radicular pain and myelopathic pain improved after radiosurgery in most cases (94%). Motor weakness recovered in two out of five patients and recovery of sensory change occurred in four out of ten patients. In two patients, symptoms were aggravated by tumor enlargement and the occurrence of new lesion. Mean spinal cord volumes receiving more than 10 and 8 Gy were 0.40 ± 0.4 and 0.81 ± 0.7 cm3, respectively. Stereotactic radiosurgery (SRS) using the Cyberknife showed the ability to control benign spinal tumors without complication in most cases.
Benign spinal tumor Cyberknife Radiosurgery
This is a preview of subscription content, log in to check access.
Gerszten PC, Ozhasoglu C, Burton SA, Vogel WJ, Atkins BA, Kalnicki S et al (2003) CyberKnife frameless single-fraction stereotactic radiosurgery for benign tumors of the spine. Neurosurg Focus 14(5):e16CrossRefPubMedGoogle Scholar
Ryu SI, Kim DH, Chang SD (2003) Stereotactic radiosurgery for hemangiomas and ependymomas of the spinal cord. Neurosurg Focus 15(5):E10CrossRefPubMedGoogle Scholar
Sahgal A, Chou D, Ames C, Ma L, Lamborn K, Huang K et al (2007) Image-guided robotic stereotactic body radiotherapy for benign spinal tumors: The University of California San Francisco preliminary experience. Technol Cancer Res Treat 6(6):595–604PubMedGoogle Scholar
Kondziolka D, Nathoo N, Flickinger JC, Niranjan A, Maitz AH, Lunsford LD (2003) Long-term results after radiosurgery for benign intracranial tumors. Neurosurgery 53(4):815–821 (discussion 821–822)PubMedGoogle Scholar
Kondziolka D, Lunsford LD, McLaughlin MR, Flickinger JC (1998) Long-term outcomes after radiosurgery for acoustic neuromas. N Engl J Med 339(20):1426–1433CrossRefPubMedGoogle Scholar
Benzil DL, Saboori M, Mogilner AY, Rocchio R, Moorthy CR (2004) Safety and efficacy of stereotactic radiosurgery for tumors of the spine. J Neurosurg 101(Suppl 3):413–418PubMedGoogle Scholar
Bhatnagar AK, Gerszten PC, Ozhasaglu C, Vogel WJ, Kalnicki S, Welch WC et al (2005) CyberKnife frameless radiosurgery for the treatment of extracranial benign tumors. Technol Cancer Res Treat 4(5):571–576PubMedGoogle Scholar
Cheshier SH, Hanft SJ, Adler JR, Chang SD (2007) CyberKnife radiosurgery for lesions of the foramen magnum. Technol Cancer Res Treat 6(4):329–336PubMedGoogle Scholar
Gerszten PC, Ozhasoglu C, Burton SA, Vogel WJ, Atkins BA, Kalnicki S et al (2004) CyberKnife frameless stereotactic radiosurgery for spinal lesions: clinical experience in 125 cases. Neurosurgery 55(1):89–98 (discussion 98–99)PubMedGoogle Scholar
Chang EL, Shiu AS, Mendel E, Mathews LA, Mahajan A, Allen PK et al (2007) Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure. J Neurosurg Spine 7(2):151–160. doi:10.3171/SPI-07/08/151CrossRefPubMedGoogle Scholar
Yamada Y, Bilsky MH, Lovelock DM, Venkatraman ES, Toner S, Johnson J et al (2008) High-dose, single-fraction image-guided intensity-modulated radiotherapy for metastatic spinal lesions. Int J Radiat Oncol Biol Phys 71(2):484–490. doi:10.1016/j.ijrobp.2007.11.046CrossRefPubMedGoogle Scholar
Schultheiss TE, Kun LE, Ang KK, Stephens LC (1995) Radiation response of the central nervous system. Int J Radiat Oncol Biol Phys 31(5):1093–1112CrossRefPubMedGoogle Scholar